| Literature DB >> 34163445 |
Wenwen Liu1,2, Qiang Wang2, Jiajia Song2, Jinwei Xin3,4, Songshan Zhang1, Yuanhua Lei1, Yuanli Yang1, Peng Xie1, Huayi Suo2.
Abstract
Gut microbiota are closely linked to host health and adaptability to different geographical environments. However, information on the influence of different geographical conditions on the intestinal microbiota of yaks is limited. In this study, 18 yak fecal samples were collected from three regions of China, namely Shangri-la, Lhasa, and Yushu, and were analyzed via high-throughput sequencing. The alpha diversity, as measured by the Shannon, ACE, and Chao indices, was the highest in the Shangri-la samples. Principal coordinate analysis detected significant differences in the composition of the intestinal microbiota of yaks from different regions. A total of six phyla, 21 families, and 29 genera were identified in the fecal samples. The dominant phyla in the samples were Firmicutes and Bacteroidetes, and the most abundant family was Ruminococcaceae. In addition, Ruminococcaceae_UCG-005 was the predominant genus and was more abundant in Yushu samples than in other samples. However, the predicted functional gene composition of the gut microbiota of yaks from different regions was similar. Our results revealed that geographical conditions influence the diversity and composition of the intestinal microbiota of yaks.Entities:
Keywords: diversity; geographical regions; gut microbiota; high-throughput sequencing; yak
Year: 2021 PMID: 34163445 PMCID: PMC8216380 DOI: 10.3389/fmicb.2021.666940
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Sampling sites in this research, including Lhasa, Yushu, and Shangri-la. The three sampling locations are represented by different shapes on the map. Triangle: Yushu (Qinghai Province); pentagon: Lhasa (Tibet Autonomous Region); circle: Shangri-La (Yunnan Province).
FIGURE 2Alpha diversity of gut bacteria among different places. (A) The Shannon index of each region. (B) The ACE index of each region. (C) The Chao index of each region. *indicates that differences between groups are significant, p < 0.05; **indicates that differences between groups are very significant, p < 0.01.
FIGURE 3Principal coordinates analysis (PCoA) of gut microbiota between different regions. (A) PCoA results based on unweighted UniFrac distance of bacterial communities from different regions. (B) PCoA results based on weighted UniFrac distance of bacterial communities from different regions. (C) The distinct separation of samples from different regions shown on the PCo1 axis based on weighted UniFrac distance. (D) The distinct separation of samples from different regions shown on the PCo1 axis based on unweighted UniFrac distance.
FIGURE 4Composition of gut microbiota of yaks from different regions. (A) Venn analysis. (B) Relative abundance of community at the phylum level. (C) Relative abundance of community at the family level. (D) Relative abundance of community at the genus level.
FIGURE 5Statistical comparison of the relative abundance of yak gut bacteria among different regions. (A) Comparison of dominant phyla in the Shangri-la, Lhasa, and Yushu groups. (B) Comparison of dominant families in the Shangri-la, Lhasa, and Yushu groups. (C) Comparison of dominant genera in the Shangri-la, Lhasa, and Yushu groups.
FIGURE 6LEfSe analysis of gut microbiota. (A) Linear discriminant analysis (LDA) effect size (LEfSe) conducted on the intestinal microbiota of yaks from different regions (p < 0.05, LDA > 3). Different colors and sizes of nodes indicate microbial groups with significant differences and enriched species abundance. Light yellow nodes indicate groups with no significant difference. (B) LEfSe for three regions.
The predicted functional composition (%) of the microbiota of yaks from different regions.
| Cellular processes | 6.07 ± 0.19a | 5.63 ± 0.34b | 5.98 ± 0.22a |
| Environmental information processing | 7.14 ± 0.29a | 6.19 ± 0.52b | 6.58 ± 0.32b |
| Genetic information processing | 12.86 ± 0.09b | 13.31 ± 0.57a | 13.18 ± 0.14ab |
| Human diseases | 4.17 ± 0.03a | 4.20 ± 0.05a | 4.15 ± 0.09a |
| Metabolism | 67.45 ± 0.52b | 68.32 ± 0.38a | 67.81 ± 0.56ab |
| Organismal systems | 2.31 ± 0.03a | 2.35 ± 0.08a | 2.29 ± 0.03a |
Predicted functional composition (%) of microbiota relating to metabolism.
| Amino acid metabolism | 10.41 ± 0.05 | 10.58 ± 0.16b | 10.75 ± 0.07a |
| Biosynthesis of other secondary metabolites | 1.94 ± 0.05b | 2.02 ± 0.05a | 1.97 ± 0.06ab |
| Carbohydrate metabolism | 14.27 ± 0.21a | 14.15 ± 0.10ab | 13.99 ± 0.13b |
| Energy metabolism | 6.40 ± 0.07b | 6.54 ± 0.13a | 6.39 ± 0.07b |
| Global and overview maps | 12.84 ± 0.14b | 12.79 ± 0.41b | 13.20 ± 0.09a |
| Glycan biosynthesis and metabolism | 2.37 ± 0.21a | 2.63 ± 0.34a | 2.37 ± 0.19a |
| Lipid metabolism | 2.86 ± 0.02a | 2.92 ± 0.07a | 2.86 ± 0.06a |
| Metabolism of cofactors and vitamins | 6.17 ± 0.07a | 6.20 ± 0.09a | 6.15 ± 0.10a |
| Metabolism of other amino acids | 1.79 ± 0.03ab | 1.85 ± 0.11a | 1.76 ± 0.03b |
| Metabolism of terpenoids and polyketides | 1.47 ± 0.01b | 1.55 ± 0.09a | 1.50 ± 0.02ab |
| Nucleotide metabolism | 5.89 ± 0.05ab | 6.06 ± 0.25a | 5.85 ± 0.02b |
| Xenobiotics biodegradation and metabolism | 1.06 ± 0.01a | 1.03 ± 0.07a | 1.01 ± 0.02a |
Percentage composition of other functional genes of the microbiota of yaks from different regions.
| Cell motility | 1.58 ± 0.15a | 1.26 ± 0.26b | 1.56 ± 0.18a |
| Cell growth and death | 0.93 ± 0.03b | 1.01 ± 0.06a | 0.94 ± 0.04b |
| Transport and catabolism | 0.35 ± 0.05a | 0.41 ± 0.07a | 0.35 ± 0.05a |
| Cellular community – eukaryotes | 0.00 ± 0.00a | 0.00 ± 0.00a | 0.00 ± 0.00a |
| Cellular community – prokaryotes | 3.21 ± 0.12a | 2.92 ± 0.21b | 3.13 ± 0.14a |
| Signal transduction | 2.83 ± 0.11a | 2.58 ± 0.14b | 2.75 ± 0.10a |
| Membrane transport | 4.30 ± 0.18a | 3.61 ± 0.39b | 3.84 ± 0.22b |
| Signaling molecules and interaction | 0.00 ± 0.00a | 0.00 ± 0.00a | 0.00 ± 0.00a |
| Replication and repair | 4.76 ± 0.02b | 4.96 ± 0.25a | 4.87 ± 0.04ab |
| Translation | 5.49 ± 0.06b | 5.71 ± 0.26a | 5.64 ± 0.07ab |
| Transcription | 0.26 ± 0.00a | 0.26 ± 0.01a | 0.26 ± 0.01a |
| Folding, sorting and degradation | 2.34 ± 0.02b | 2.39 ± 0.07a | 2.40 ± 0.02a |
| Cancers: Overview | 0.64 ± 0.01a | 0.66 ± 0.03a | 0.65 ± 0.02a |
| Cardiovascular diseases | 0.27 ± 0.00ab | 0.26 ± 0.02b | 0.28 ± 0.00a |
| Immune diseases | 0.05 ± 0.00a | 0.05 ± 0.01a | 0.04 ± 0.00b |
| Infectious diseases: Parasitic | 0.03 ± 0.00b | 0.05 ± 0.03a | 0.04 ± 0.01ab |
| Drug resistance: Antimicrobial | 1.55 ± 0.02a | 1.48 ± 0.07b | 1.49 ± 0.02ab |
| Infectious diseases: Bacterial | 0.70 ± 0.01a | 0.67 ± 0.03b | 0.64 ± 0.00 |
| Drug resistance: Antineoplastic | 0.36 ± 0.00b | 0.38 ± 0.01a | 0.39 ± 0.01a |
| Endocrine and metabolic diseases | 0.33 ± 0.00b | 0.32 ± 0.01b | 0.34 ± 0.00a |
| Neurodegenerative Diseases | 0.15 ± 0.01b | 0.18 ± 0.02a | 0.16 ± 0.02ab |
| Cancers: Specific types | 0.09 ± 0.00b | 0.11 ± 0.01a | 0.10 ± 0.01a |
| Infectious diseases: Viral | 0.01 ± 0.00a | 0.03 ± 0.01a | 0.03 ± 0.01a |
| Substance dependence | 0.00 ± 0.00a | 0.00 ± 0.00a | 0.00 ± 0.00a |
| Circulatory system | 0.00 ± 0.00a | 0.00 ± 0.00a | 0.00 ± 0.00a |
| Environmental adaptation | 0.21 ± 0.00a | 0.20 ± 0.01b | 0.20 ± 0.00a |
| Endocrine system | 0.86 ± 0.01a | 0.89 ± 0.04a | 0.86 ± 0.01a |
| Digestive system | 0.05 ± 0.01b | 0.07 ± 0.02a | 0.05 ± 0.01b |
| Excretory system | 0.04 ± 0.00ab | 0.03 ± 0.01b | 0.05 ± 0.00a |
| Immune system | 0.44 ± 0.01a | 0.43 ± 0.01a | 0.44 ± 0.01a |
| Nervous system | 0.29 ± 0.01a | 0.27 ± 0.01b | 0.29 ± 0.01a |
| Aging | 0.42 ± 0.01b | 0.45 ± 0.03a | 0.40 ± 0.01b |
| Development | 0.00 ± 0.00a | 0.00 ± 0.00a | 0.00 ± 0.00a |